Показано 0 из 0
Дата |
---|
19:15 |
02.05.2024 |
01.05.2024 |
30.04.2024 |
29.04.2024 |
26.04.2024 |
25.04.2024 |
24.04.2024 |
23.04.2024 |
22.04.2024 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
5.75
|
5.89
|
5.77
|
5.73
|
5.80
|
5.80
|
|
|
15 202.46
|
53.00
|
|
5.80
|
5.85
|
5.38
|
5.85
|
5.58
|
|
|
68 217.55
|
172.00
|
5.60
|
6.14
|
5.54
|
5.40
|
5.98
|
5.93
|
|
|
56 441.21
|
165.00
|
2.82
|
5.71
|
5.76
|
5.27
|
5.76
|
5.32
|
|
|
34 357.97
|
124.00
|
5.33
|
|
5.45
|
5.45
|
5.90
|
5.57
|
|
|
18 229.41
|
79.00
|
|
5.80
|
5.37
|
5.32
|
5.48
|
5.32
|
|
|
60 039.43
|
97.00
|
|
6.09
|
5.25
|
5.25
|
5.51
|
5.45
|
|
|
28 489.05
|
126.00
|
4.46
|
5.84
|
5.54
|
5.41
|
5.76
|
5.46
|
|
|
29 510.35
|
137.00
|
5.04
|
5.80
|
5.52
|
5.50
|
6.04
|
5.50
|
|
|
41 317.39
|
198.00
|
4.96
|
5.84
|
5.74
|
5.50
|
5.82
|
5.50
|
|
|
30 266.06
|
122.00
|
Monte Rosa Therapeutics, Inc. operates as a biotechnology company. The Company focuses on developing molecular glues to degrade disease-causing proteins. Monte Rosa Therapeutics serves customers in the United States and Switzerland.